Cleared Traditional

K792472 - ELECTRO-IMMUNO-QUANTITATION (EIQ)

K792472 is the FDA 510(k) clearance for ELECTRO-IMMUNO-QUANTITATION (EIQ) by Icl Scientific. It is a Class 2 Immunology device (product code DAK) cleared through the Traditional 510(k) pathway after a 24-day FDA review.

K792472 · Icl Scientific · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1979
Decision
24d
Days
Class 2
Risk

K792472 is an FDA 510(k) clearance for the ELECTRO-IMMUNO-QUANTITATION (EIQ). Classified as Complement C1q, Antigen, Antiserum, Control (product code DAK), Class II - Special Controls.

Submitted by Icl Scientific (Mchenry, US). The FDA issued a Cleared decision on December 27, 1979 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5240 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Icl Scientific devices

Submission Details

510(k) Number K792472 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 1979
Decision Date December 27, 1979
Days to Decision 24 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 104d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DAK Complement C1q, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5240
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DAK Complement C1q, Antigen, Antiserum, Control

All 13
Devices cleared under the same product code (DAK) and FDA review panel - the closest regulatory comparables to K792472.
ORTHO* SERUM ELISA TEST SYSTEM
K833636 · Ortho Diagnostic Systems, Inc. · Jun 1984
ORTHO* ALTERNATIVE PATHWAY COMPL. TEST
K821949 · Ortho Diagnostic Systems, Inc. · Aug 1982
ORTHO CLG IMMUNE COMPLEX TEST SYSTEM
K821806 · Ortho Diagnostic Systems, Inc. · Jun 1982
ANTI-HUMAN CIQ SERUM
K781022 · Icl Scientific · Aug 1978
LAS-R HUMAN COMPLEMENT CLQ TEST
K780729 · Hyland Therapeutic Div., Travenol Laboratories · May 1978
HUMAN REFERENCE SERUM C4 COMPLEMENT
K772003 · G.D. Searle and Co. · Nov 1977